Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Blanco Fernandez et al., 2022
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/216396

Bioprinting Decellularized Breast Tissue for the Development of Three-Dimensional Breast Cancer Models

Journal Title

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

The tumor extracellular matrix (ECM) plays a vital role in tumor progression and drug resistance. Previous studies have shown that breast tissue-derived matrices could be an important biomaterial to recreate the complexity of the tumor ECM. We have developed a method for decellularizing and delipidating a porcine breast tissue (TDM) compatible with hydrogel formation. The addition of gelatin methacrylamide and alginate allows this TDM to be bioprinted by itself with good printability, shape fidelity, and cytocompatibility. Furthermore, this bioink has been tuned to more closely recreate the breast tumor by incorporating collagen type I (Col1). Breast cancer cells (BCCs) proliferate in both TDM bioinks forming cell clusters and spheroids. The addition of Col1 improves the printability of the bioink as well as increases BCC proliferation and reduces doxorubicin sensitivity due to a downregulation of HSP90. TDM bioinks also allow a precise three-dimensional printing of scaffolds containing BCCs and stromal cells and could be used to fabricate artificial tumors. Taken together, we have proven that these novel bioinks are good candidates for biofabricating breast cancer models.

Citation

Citation

BLANCO FERNANDEZ, Barbara, et al. Bioprinting Decellularized Breast Tissue for the Development of Three-Dimensional Breast Cancer Models. ACS Applied Materials & Interfaces. 2022. Vol. 14, num. 26, pags. 29467-29482. ISSN 1944-8244. [consulted: 7 of October of 2026]. Available at: https://hdl.handle.net/2445/216396

Export metadata

JSON - METS

Share record